After debate over controversial drug lidocaine, long COVID patients left without treatment options: 'The fact that someone gets better means nothing'

Post-COVID patients in the Netherlands are turning to controversial and expensive lidocaine treatments at private clinics, with some claiming significant recovery. Scientists warn that individual success stories do not scientifically validate the treatment, leaving patients in a medical no-man's land without established options.

